Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and ...

Retrieved on: 2021-06-02 10:52:30

Tags for this article:

Medical specialties

Clinical medicine

Medicine

Kamada

REHOVOT

Science and technology in Israel

Post-exposure prophylaxis

Rabies

Rho(D) immune globulin

United States

Click the tags to see associated articles and topics

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and .... View article details on HISWAI: https://www.prnewswire.com/il/news-releases/kedrion-and-kamada-announce-fda-approval-of-kedrab-label-update-confirming-safety-and-effectiveness-in-children-301303676.html

Excerpt

Kedrion Biopharma is a leading international biopharmaceutical company that specializes in the development, production and distribution of plasma- ...

Article found on: www.prnewswire.com

View Original Article